Thermo Fisher Scientific
TMO
2,129 hedge funds and large institutions have $197B invested in Thermo Fisher Scientific in 2021 Q3 according to their latest regulatory filings, with 163 funds opening new positions, 800 increasing their positions, 809 reducing their positions, and 80 closing their positions.
104% more first-time investments, than exits
New positions opened: 163 | Existing positions closed: 80
39% more funds holding in top 10
Funds holding in top 10: 155 → 215 (+60)
14% more capital invested
Capital invested by funds: $173B → $197B (+$24.2B)
3% more funds holding
Funds holding: 2,075 → 2,129 (+54)
0.43% more ownership
Funds ownership: 87.41% → 87.84% (+0.43%)
1% less repeat investments, than reductions
Existing positions increased: 800 | Existing positions reduced: 809
24% less call options, than puts
Call options by funds: $1.56B | Put options by funds: $2.05B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$703M |
| 2 |
BlackRock
New York
|
+$504M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$245M |
| 4 |
RI
RTW Investments
New York
|
+$228M |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$222M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$517M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$455M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$252M |
| 4 |
SG Americas Securities
New York
|
-$249M |
| 5 |
KBC Group
Brussels,
Belgium
|
-$211M |
TMO Hedge Fund Activity: Q3 2021 in Review
2,129 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2021, worth a combined $197B — up 14% from $173B a quarter earlier.
Buyers outnumbered sellers: 163 funds opened new TMO positions and 80 closed out — a net gain of 83 holders — while 800 added to existing stakes and 809 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $703M. The largest seller was Wellington Management Group, cutting an estimated $517M.
- 2,129 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2021, up from 2,075 in Q2 2021.
- Funds reported $197B of Thermo Fisher Scientific stock for Q3 2021, up 14% quarter-over-quarter.
- 163 funds opened new Thermo Fisher Scientific positions in Q3 2021 and 80 closed out, a net change of +83 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2021 was Fidelity Investments, an estimated $703M added.
- The largest Thermo Fisher Scientific seller in Q3 2021 was Wellington Management Group, an estimated $517M sold.
Based on aggregated 13F filings for Q3 2021.